Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Geron Corporation

< Previous 1 2 3 4 Next >
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the H.C. Wainwright Global Investment Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports First Quarter 2022 Financial Results
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Announce First Quarter 2022 Financial Results on May 9, 2022
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the 21st Annual Needham Virtual Healthcare Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the H.C. Wainwright BioConnect Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Presentations at American Society of Hematology Annual Meeting
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Appointment of Chief Business Officer
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Presents Investor Event Highlights
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Host a Virtual Investor Event in November
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces September Investor Conference Presentation Webcasts
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023
From Geron Corporation
Via Business Wire
Tickers GERN
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.